Eurofins Scientific SE (ERF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
92
About the Report
About the Report
Summary
Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, pharma central laboratory, biopharma product testing, genomic services, agro-science services, product testing, forensic services, environmental testing and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) services. Its analytical methods help in evaluating the safety, identity, composition, origin, authenticity and purity of biological products and substances. It harnesses its expertise in logistics and information technology to deliver a range of services. The company operates across Europe, North and South America, and Asia-Pacific. Eurofins is headquartered in Luxembourg.
Eurofins Scientific SE (ERF)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Eurofins Scientific SE, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Eurofins Scientific SE, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Eurofins Scientific SE, Medical Devices Deals, 2012 to YTD 2018 11
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Eurofins Scientific to Acquire Testing Business from Exova 14
Amatsigroup Acquires R&D Center from Pierre Fabre Labs 15
Eurofins Scientific Acquires Assets of Discovery and Development Solutions Business of Merck 16
Viracor-IBT Labs Completes Acquisition Of Lab Operations Of National Institute of Transplantation 17
Venture Financing 18
Diatherix Secures Additional USD 0.53 Million In Venture Financing 18
Partnerships 19
GATC Biotech Enters into Agreement with University of Konstanz 19
Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 20
Qiagen Enters into Agreement with GATC Biotech 21
Merger 22
Bactimm Farma And Proxy Labs Merge To Form Sinensis Life Sciences 22
Equity Offering 23
Eurofins Scientific Raises USD347.1 Million in Private Placement of Shares 23
Eurofins Scientific Raises USD333 Million in Private Placement of Shares 24
Debt Offering 25
Eurofins Scientific Raises USD464.7 Million in Public Offering of 3.25% Bonds 25
Eurofins Scientific Raises USD745.3 Million in Public Offering of 2.125% Bonds Due 2024 26
Eurofins Scientific Raises USD554 Million in Public Offering of 3.375% Bonds Due 2023 27
Eurofins Scientific Prices USD322 Million in Public Offering of 4.87% Bond Due 2023 28
Eurofins Scientific Raises USD579 Million in Public Offering of 2.25% Bond Due 2022 29
Eurofins Prices Public Offering Of Bonds Due 2018 For USD 405.1 Million 30
Acquisition 31
Eurofins Acquires Covance from LabCorp 31
Eurofins Scientific to Acquire PHAST 33
Eurofins Scientific Acquires Selcia 34
Eurofins Pharma Services Acquires Majority Stake in Advinus Therapeutics 35
Eurofins Scientific to Acquire DiscoverX 37
Eurofins Scientific Acquires Amatsigroup from Ekkio Capital 38
Eurofins GSC Lux Acquires ANA Laboratories 39
Eurofins Scientific Acquires Alphora Research 40
Eurofins Scientific to Acquire GATC Biotech 41
Amatsigroup Acquires Disposable-Lab 42
Eurofins Scientific to Acquire Villapharma Research 43
Amatsigroup Acquires Q-Biologicals 44
Eurofins Scientific Acquires Sinensis Life Sciences 45
Eurofins Scientific Acquires 75% Stake in Emory Genetics Lab for USD40 Million 46
Eurofins Scientific Acquires QC Laboratories (QCL) 47
Amatsi Acquires Seps Pharma 48
Eurofins Scientific to Acquire SF Analytical Labs 49
Eurofins Genomics Acquires VBC-Biotech 50
Eurofins Scientific Completes Acquisition of Viracor-IBT Labs For USD255 Million 51
Eurofins Scientific Acquires IDmyk 52
Eurofins Scientific Acquires 81% Stake In Agrisearch Services 53
Eurofins Discovery Services Acquires Majority Stake In Cerep 54
Eurofins Scientific Acquires Aros Applied Biotech, Genomic Solutions Provider 55
Proxy Labs Acquires MicroSafe Laboratories From Millipore 56
Eurofins Scientific SE-Key Competitors 57
Eurofins Scientific SE-Key Employees 58
Eurofins Scientific SE-Locations And Subsidiaries 59
Head Office 59
Other Locations & Subsidiaries 59
Recent Developments 63
Financial Announcements 63
Oct 23, 2018: Eurofins posts strong revenue growth in Q3 2018 (EUR 955m, +30.6% yoy including over 5% organic growth) and raises its objectives for 2019-2020-Revenues objective for 2020 now set at EUR 5bn 63
Jul 31, 2018: Eurofins delivers strong revenue, profitability and cash flow growth in H1 2018 65
Jun 26, 2018: Eurofins raises its revenues objectives for 2018 to EUR 3.8bn (4bn pro-forma), to 4.3bn for 2019 and to 4.7bn for 2020 71
Apr 24, 2018: Eurofins revenues grow +23% in Q1 2018 to EUR 839m 72
Mar 06, 2018: Eurofins exceeds its recently-upgraded 2017 objectives on a strong growth momentum and raises its objectives for 2018 73
Oct 24, 2017: After Strong NM 2017 Performance Eurofins Brings Forward by 1 Year, to 2019, Its EUR 4bn Annual Revenues Objective 80
Aug 30, 2017: Eurofins Reports Solid H1 2017 Results 81
Feb 28, 2017: Eurofins: Full Year 2016 Results 86
Product News 91
Oct 02, 2018: Eurofins BioPharma Product Testing Ireland opened the new extension in Dungarvan 91
Appendix 92
Methodology 92
About GlobalData 92
Contact Us 92
Disclaimer 92
List of Figure
List of Figures
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Eurofins Scientific SE, Medical Devices Deals, 2012 to YTD 2018 11
List of Table
List of Tables
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Eurofins Scientific SE, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Eurofins Scientific SE, Deals By Therapy Area, 2012 to YTD 2018 10
Eurofins Scientific SE, Medical Devices Deals, 2012 to YTD 2018 11
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Eurofins Scientific to Acquire Testing Business from Exova 14
Amatsigroup Acquires R&D Center from Pierre Fabre Labs 15
Eurofins Scientific Acquires Assets of Discovery and Development Solutions Business of Merck 16
Viracor-IBT Labs Completes Acquisition Of Lab Operations Of National Institute of Transplantation 17
Diatherix Secures Additional USD 0.53 Million In Venture Financing 18
GATC Biotech Enters into Agreement with University of Konstanz 19
Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 20
Qiagen Enters into Agreement with GATC Biotech 21
Bactimm Farma And Proxy Labs Merge To Form Sinensis Life Sciences 22
Eurofins Scientific Raises USD347.1 Million in Private Placement of Shares 23
Eurofins Scientific Raises USD333 Million in Private Placement of Shares 24
Eurofins Scientific Raises USD464.7 Million in Public Offering of 3.25% Bonds 25
Eurofins Scientific Raises USD745.3 Million in Public Offering of 2.125% Bonds Due 2024 26
Eurofins Scientific Raises USD554 Million in Public Offering of 3.375% Bonds Due 2023 27
Eurofins Scientific Prices USD322 Million in Public Offering of 4.87% Bond Due 2023 28
Eurofins Scientific Raises USD579 Million in Public Offering of 2.25% Bond Due 2022 29
Eurofins Prices Public Offering Of Bonds Due 2018 For USD 405.1 Million 30
Eurofins Acquires Covance from LabCorp 31
Eurofins Scientific to Acquire PHAST 33
Eurofins Scientific Acquires Selcia 34
Eurofins Pharma Services Acquires Majority Stake in Advinus Therapeutics 35
Eurofins Scientific to Acquire DiscoverX 37
Eurofins Scientific Acquires Amatsigroup from Ekkio Capital 38
Eurofins GSC Lux Acquires ANA Laboratories 39
Eurofins Scientific Acquires Alphora Research 40
Eurofins Scientific to Acquire GATC Biotech 41
Amatsigroup Acquires Disposable-Lab 42
Eurofins Scientific to Acquire Villapharma Research 43
Amatsigroup Acquires Q-Biologicals 44
Eurofins Scientific Acquires Sinensis Life Sciences 45
Eurofins Scientific Acquires 75% Stake in Emory Genetics Lab for USD40 Million 46
Eurofins Scientific Acquires QC Laboratories (QCL) 47
Amatsi Acquires Seps Pharma 48
Eurofins Scientific to Acquire SF Analytical Labs 49
Eurofins Genomics Acquires VBC-Biotech 50
Eurofins Scientific Completes Acquisition of Viracor-IBT Labs For USD255 Million 51
Eurofins Scientific Acquires IDmyk 52
Eurofins Scientific Acquires 81% Stake In Agrisearch Services 53
Eurofins Discovery Services Acquires Majority Stake In Cerep 54
Eurofins Scientific Acquires Aros Applied Biotech, Genomic Solutions Provider 55
Proxy Labs Acquires MicroSafe Laboratories From Millipore 56
Eurofins Scientific SE, Key Competitors 57
Eurofins Scientific SE, Key Employees 58
Eurofins Scientific SE, Subsidiaries 59
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.